Toxicoproteomics: First experiences in a BMBF-study;Toxikoproteomics: Erste erfahrungen in einer BMBF-Studie

Altex

Volumn 21, Issue SUPPL. 3, 2004, Pages 28-40

  Kröger, Michaela ^a   Hellmann, Jürgen ^a   Toldo, Luca ^a   Glückmann, Matthias ^b   von Eiff, Bettina ^a   Fella, Kerstin ^a   Kramer, Peter Jürgen ^a  

^a MERCK KGAA   (Germany)

^b Applied Biosystems   (Germany)

Author keywords

2DE; Biomarker; Molecular toxicology; Predictive toxicology; SELDI; Toxicoproteomics

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN; PROTEOME;

ANIMAL TISSUE; ARTICLE; BIOASSAY; CARCINOGENICITY; CLUSTER ANALYSIS; CONTROLLED STUDY; DEREGULATION; DISEASE MODEL; HISTOPATHOLOGY; LIVER CANCER; LIVER CARCINOGENESIS; LIVER TOXICITY; MALE; MASS SPECTROMETRY; MOLECULAR MECHANICS; NONHUMAN; PREDICTION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEOMICS; RAT; RISK ASSESSMENT; TOXICITY TESTING; TOXICOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; BIOLOGICAL ASSAY; CARCINOGENS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MASS SPECTROMETRY; PROTEOME; PROTEOMICS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RISK ASSESSMENT; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 3242768405     PISSN: 09467785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bandara, L. R. and Kennedy, S. (2002). Toxicoproteomics - a new preclinical tool. Drug Discov. Today 7, 411-418.
2. Bannasch, P., Hacker, H., Klimek, F. and Mayer, D. (1982). Hepatocellular glycogenesis and related pattern of enzymatic changes during hepatocarcinogenesis. Adv. Enzyme Regul. 22, 97-121.
3. Bannasch, P., Nehrbass, D. and Kopp-Schneider, A. (2001). Significance of hepatic preneoplasia for cancer chemoprevention. In A. B. Miller, H. Bartsch, P. Bofletta, L. Dragsted and H. Vainio (Ed.), Biomarkers in Cancer Chemoprevention (223-240). IARC Scientific Publications.
4. Combes, R., Barratt, M. and Balls, M. (2003). An Overall Strategy for the Testing of Chemicals for Human Hazard and Risk Assessment under the EU REACH System. ATLA 31, 7-19.
5. Degterev, A., Boyce, M. and Yan, J. (2003). A decade of caspases. Oncogene 22 (53), 8543-8567.
6. Elcombe, C. R., Odum, J., Foster, J. R. et al. (2002). Prediction of rodent nongenotoxic carcinogenesis: evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens. Environ. Health Perspect. 110, 363-375.
7. Görg, A. and Weiss, W. (2000). Two-dimensional electrophoresis with immobilized pH gradients. In T. Rabilloud (Ed.), Proteome research: two-dimensional gel electrophoresis and identification methods (57-93). Wien, New York: Springer-Verlag.
8. Groopman, J. D. and Kensler, T. W. (1999). The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight? Carcinogenesis 20, 1-11.
9. Hiroyuki, T., Shoji, F., Hideki, W. et al. (2003). Value of GST-P Positive Prencoplastic Hepatic Foci in Dose-Response Studies of Hepatocarcinogenesis: Evidence for Practical Thresholds with Both Genotoxic and Nongenotoxic Carcinogens. Toxicol. Pathology 31, 80-86.
10. Hutchens, T. W. and Yip, T. T. (1993). New Desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Comm. Mass Spectrom. 7, 576-576.
11. Iida, M., Anna, C. H., Hartis, J. et al. (2003). Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643. Carrinogenesis 24, 757-770.
12. Ittrich, C., Deml, E., Oesterle, D. et al. (2003). Prevalidation of a rat liver foci bioassay (RLFB) based on results from 1600 rats: a study report. Toxicologic. Pathology 31, 60-79.
13. Kohen, R. and Nyska, A. (2002). Oxidation of Biological Systems: Oxidative Stress Phenomena, Antioxidants, Redox Reactions, and Methods for Their Quantification. Toxicol. Pathology 30, 620-650.
14. MacGregor, J. T., Farr, S., Tucker, J. D. et al. (1995). New molecular endpoints and methods for routine toxicity testing. Fundam. Appl. Toxicol. 26, 156-173.
15. Mayer, D., Metzger, C., Leonetti, P. et al. (1998). Differential expression of key enzymes of energy metabolism in preneoplastic and neoplastic rat liver lesions induced by N-nitrosomorpholine and dehydroepiandrosterone. Int. J. Cancer 79, 232-240.
16. Merrick, A. and Tomer, K. B. (2003). Toxicoproteomics: a parallel approach to identifying biomarkers. Environ. Health Perspect. 111, A578-A579.
17. Moore, M. A., Tsuda, H., Tamano, S. et al. (1999). Marriage of a medium-term liver model to surrogate markers - a practical approach for risk and benefit assessment. Toxicol. Pathol. 27, 237-242.
18. Oberemm, A. (2001). Molekulare Biomarker zur schnellen Erfassung und Bewertung toxischer Chemikalieneffekte. UMID 2, 3-6.
19. Petricoin, E. F., Ardekani, A. M., Hitt, B. A. et al. (2002). Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359, 572-577.
20. Ramos, K. S. and Goehl, T. J. (2003). Toxicogenomics: An EHP section. Environ. Health Perspect. 111, A328-A328.
21. Richter-Reichhelm, H. B. (1989). View of the regulatory use of rat liver foci data in the Federal Republic of Germany. Toxicol. Pathol. 17, 721-723.
22. Schramek, K., Schumacher, M., Wilflingseder, D. et al. (1997). Differential expression and activation of MAP kinases in dedifferentiated MDCK-focus cells. Am. J. Physiol. 272(2Pt1), C383-391.
23. Sills, R. C., French, J. E. and Cunningham, M. L. (2001). New models for assessing carcinogenesis: an ongoing process. Toxicol. Lett. 120, 187-198.
24. Tennant, R. W. (2002). The national center for toxicogenomics: Using new technologies to inform mechanistic toxicology. Environ. Health Perspect. 110, A8-A10.
25. Toraason, M., Andersen, M., Bogdanffy, M. S. et al. (2002). Improving risk assessment: Toxicological research needs. Human and Ecological Risk Assessment 8, 1405-1419.
26. Waring, J. F., Ciurlionis, R., Jolly, R. A. et al. (2001). Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol. Lett. 120, 359-368.
27. Weber, E. and Bannasch, P. (1994). Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to N-nitrosomorpholine. Carcinogenesis 15 (6), 1227-1234.
28. Wiesner, A. (2002). Das ProteinChip-System von Ciphergen Biosystems Inc.. Transcript. Laborwelt III(1), 47-49.